Patents by Inventor Kent K. Grindstaff

Kent K. Grindstaff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11753445
    Abstract: Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.
    Type: Grant
    Filed: April 11, 2022
    Date of Patent: September 12, 2023
    Assignee: COHBAR, INC.
    Inventors: Kenneth Cundy, Remi Magnan, Kent K. Grindstaff, Wendy Luo, Yongjin Yao, Liang Zeng Yan
  • Patent number: 11517608
    Abstract: A formulation comprising glutamic acid, or a salt thereof, and an effective amount of a peptide is provided. The invention also provides a method of preparing the formulation, methods of treating a condition using the formulation, and a kit containing components of the formulation. The invention further provides a sustained release formulation for drug substances comprising glutamic acid, or a salt thereof, and an amount of a peptide.
    Type: Grant
    Filed: March 27, 2019
    Date of Patent: December 6, 2022
    Assignee: COHBAR, INC.
    Inventors: Kenneth Cundy, Kent K. Grindstaff, Remi Magnan
  • Publication number: 20220242912
    Abstract: Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.
    Type: Application
    Filed: April 11, 2022
    Publication date: August 4, 2022
    Inventors: Kenneth Cundy, Remi Magnan, Kent K. Grindstaff, Wendy Luo, Yongjin Yao, Liang Zeng Yan
  • Patent number: 11332497
    Abstract: Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.
    Type: Grant
    Filed: August 4, 2021
    Date of Patent: May 17, 2022
    Assignee: COHBAR, INC.
    Inventors: Kenneth C. Cundy, Kent K. Grindstaff, Remi Magnan, Wendy Luo, Yongjin Yao, Liang Zeng Yan
  • Publication number: 20210363187
    Abstract: Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.
    Type: Application
    Filed: August 4, 2021
    Publication date: November 25, 2021
    Inventors: Kenneth C. Cundy, Kent K. Grindstaff, Remi Magnan, Wendy Luo, Yongjin Yao, Liang Zeng Yan
  • Patent number: 11111271
    Abstract: Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: September 7, 2021
    Assignee: COHBAR, INC.
    Inventors: Kenneth C. Cundy, Kent K. Grindstaff, Remi Magnan, Wendy Luo, Yongjin Yao, Liang Zeng Yan
  • Publication number: 20210030835
    Abstract: A formulation comprising glutamic acid, or a salt thereof, and an effective amount of a peptide is provided. The invention also provides a method of preparing the formulation, methods of treating a condition using the formulation, and a kit containing components of the formulation. The invention further provides a sustained release formulation for drug substances comprising glutamic acid, or a salt thereof, and an amount of a peptide.
    Type: Application
    Filed: March 27, 2019
    Publication date: February 4, 2021
    Inventors: Kenneth Cundy, Kent K. Grindstaff, Remi Magnan
  • Publication number: 20200181197
    Abstract: Provided herein are peptides and peptide analogs and methods of treating a metabolic disease, e.g., obesity, diabetes, methods of treating cancer, methods of treating a liver disease, and methods of modulating fatty acid metabolism.
    Type: Application
    Filed: September 27, 2017
    Publication date: June 11, 2020
    Inventors: Kenneth C. Cundy, Kent K. Grindstaff, Remi Magnan, Wendy Luo, Yongjin Yao, Liang Zeng Yan